270 related articles for article (PubMed ID: 30556647)
1. Six-gene Assay as a new biomarker in the blood of patients with colorectal cancer: establishment and clinical validation.
Shou X; Li Y; Hu W; Ye T; Wang G; Xu F; Sui M; Xu Y
Mol Oncol; 2019 Apr; 13(4):781-791. PubMed ID: 30556647
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor cell enumeration for improved screening and disease detection of patients with colorectal cancer.
Tsai WS; Hung WS; Wang TM; Liu H; Yang CY; Wu SM; Hsu HL; Hsiao YC; Tsai HJ; Tseng CP
Biomed J; 2021 Dec; 44(6 Suppl 2):S190-S200. PubMed ID: 35292267
[TBL] [Abstract][Full Text] [Related]
3. Highly Correlated Recurrence Prognosis in Patients with Metastatic Colorectal Cancer by Synergistic Consideration of Circulating Tumor Cells/Microemboli and Tumor Markers CEA/CA19-9.
Chu HY; Yang CY; Yeh PH; Hsu CJ; Chang LW; Chan WJ; Lin CP; Lyu YY; Wu WC; Lee CW; Wu JK; Jiang JK; Tseng FG
Cells; 2021 May; 10(5):. PubMed ID: 34068719
[TBL] [Abstract][Full Text] [Related]
4. Clinical Potential of Circulating Tumor Cells in Colorectal Cancer: A Prospective Study.
Baek DH; Kim GH; Song GA; Han IS; Park EY; Kim HS; Jo HJ; Ko SH; Park DY; Cho YK
Clin Transl Gastroenterol; 2019 Jul; 10(7):e00055. PubMed ID: 31246593
[TBL] [Abstract][Full Text] [Related]
5. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
[TBL] [Abstract][Full Text] [Related]
6. Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individuals.
Thorsen SB; Lundberg M; Villablanca A; Christensen SL; Belling KC; Nielsen BS; Knowles M; Gee N; Nielsen HJ; Brünner N; Christensen IJ; Fredriksson S; Stenvang J; Assarsson E
J Transl Med; 2013 Oct; 11():253. PubMed ID: 24107468
[TBL] [Abstract][Full Text] [Related]
7. Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and Cancer.
Tsai WS; You JF; Hung HY; Hsieh PS; Hsieh B; Lenz HJ; Idos G; Friedland S; Yi-Jiun Pan J; Shao HJ; Wu JC; Lai JM; Chang SE; Mei R; Watson D; Javey M; Nimgaonkar A
Clin Transl Gastroenterol; 2019 Oct; 10(10):e00088. PubMed ID: 31663904
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver.
Kaifi JT; Kunkel M; Dicker DT; Joude J; Allen JE; Das A; Zhu J; Yang Z; Sarwani NE; Li G; Staveley-O'Carroll KF; El-Deiry WS
Cancer Biol Ther; 2015; 16(5):690-8. PubMed ID: 25785486
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab.
Musella V; Pietrantonio F; Di Buduo E; Iacovelli R; Martinetti A; Sottotetti E; Bossi I; Maggi C; Di Bartolomeo M; de Braud F; Daidone MG; Cappelletti V
Int J Cancer; 2015 Sep; 137(6):1467-74. PubMed ID: 25704501
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of TEM-8 and CEA tumor markers indicating free tumor cells in the peripheral blood of colorectal cancer patients.
Raeisossadati R; Farshchian M; Ganji A; Tavassoli A; Velayati A; Dadkhah E; Chavoshi S; Mehrabi Bahar M; Memar B; Rajabi Mashhadi MT; Naseh H; Forghanifard MM; Moghbeli M; Moaven O; Abbaszadegan MR
Int J Colorectal Dis; 2011 Oct; 26(10):1265-70. PubMed ID: 21573768
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
[TBL] [Abstract][Full Text] [Related]
13. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.
Shen C; Hu L; Xia L; Li Y
Jpn J Clin Oncol; 2008 Nov; 38(11):770-6. PubMed ID: 18845519
[TBL] [Abstract][Full Text] [Related]
14. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
15. The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis.
Tan Y; Wu H
Curr Probl Cancer; 2018; 42(1):95-106. PubMed ID: 29277243
[TBL] [Abstract][Full Text] [Related]
16. Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients - a prospective study.
Hinz S; Hendricks A; Wittig A; Schafmayer C; Tepel J; Kalthoff H; Becker T; Röder C
BMC Cancer; 2017 Jan; 17(1):53. PubMed ID: 28086834
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cells are associated with diffuse spread in stage IV colorectal cancer patients.
Kaifi JT; Kunkel M; Zhu J; Dicker DT; Gusani N; Yang Z; Sarwani NE; Li G; Kimchi ET; Staveley-O'Carroll KF; El-Deiry WS
Cancer Biol Ther; 2013 Dec; 14(12):1174-81. PubMed ID: 24153154
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients.
de Albuquerque A; Kubisch I; Stölzel U; Ernst D; Boese-Landgraf J; Breier G; Stamminger G; Fersis N; Kaul S
J Transl Med; 2012 Nov; 10():222. PubMed ID: 23146106
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of colorectal cancer based on folate receptor-positive circulating tumor cell analysis: a retrospective cohort study.
Wei ZJ; Zhou BC; Wang GX; Han WX; Li YX; Xu AM
Int J Clin Oncol; 2024 Feb; 29(2):149-158. PubMed ID: 38112831
[TBL] [Abstract][Full Text] [Related]
20. A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer.
Barbazán J; Muinelo-Romay L; Vieito M; Candamio S; Díaz-López A; Cano A; Gómez-Tato A; Casares de Cal Mde L; Abal M; López-López R
Int J Cancer; 2014 Dec; 135(11):2633-43. PubMed ID: 24752533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
